3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Myeloid
1
Classical hematology
1
Conditions
Polycystic Ovary Syndrome
7
Neoplasms
6
Breast Neoplasms
6
Vomiting
2
Solid Tumors
2
Skin Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Diabetes Mellitus
2
Weight Gain
1
Venous Thromboembolism
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thrombocythemia, Essential
1
Stem Cell Transplant Complications
1
Skin Toxicity
1
Renal Insufficiency
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Premature Birth
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pre-Eclampsia
1
Polycythemia Vera
1
Parathyroid Neoplasms
1
Pain, Postoperative
1
Ovarian Neoplasms
1
Nausea
1
Myeloproliferative Disorders
1
Multiple Myeloma
1
Interventions
fludarabine phosphate
20
Peripheral Blood Stem Cell Transplantation
20
Cyclophosphamide
17
Busulfan
16
ruxolitinib
14
Tacrolimus
12
Whole-Body Irradiation
9
Mycophenolic Acid
9
Methotrexate
8
Antilymphocyte Serum
8
Cyclosporine
7
peginterferon alfa-2a
6
Hydroxyurea
6
Filgrastim
6
Etoposide
6
Aspirin
6
fludarabine
5
Prednisone
5
Melphalan
5
Imatinib Mesylate
5
Cytarabine
5
Decitabine
4
pomalidomide
3
givinostat hydrochloride
3
givinostat
3
Topotecan
3
Thiotepa
3
Radiotherapy
3
Lenalidomide
3
Carboplatin
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Polycythemia Vera
×
Tablets
×
Clear all
NCT04243122
2024-05-29
AIRPORT-MPN
Ottawa Hospital Research Institute
Phase 2
Completed
44 enrolled